BioCentury
ARTICLE | Clinical News

NOxCF regulatory update

May 11, 2015 7:00 AM UTC

The European Commission granted Orphan Drug designation to AIT’s AIT-CF to treat cystic fibrosis (CF). The inhaled nitric oxide formulation using the company’s drug delivery system has completed a Ph...